Med schools don't police pharma gifts, report says

A new ranking from the American Medical Student Association shows that most medical schools in the United States don't keep a sharp enough eye on the money, gifts, and drug samples companies hand out to doctors and trainees; only seven of the 150 schools got a grade of "A" for their conflict of interest policies. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.